Ultragenyx Pharmaceutical Inc.RARENASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank93
3Y CAGR+48.3%
5Y CAGR-9.5%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+48.3%/yr
vs +4.0%/yr prior
5Y CAGR
-9.5%/yr
Recent acceleration
Acceleration
+44.3pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $434.00M | +149.8% |
| 2024 | $173.73M | -18.7% |
| 2023 | $213.58M | +60.7% |
| 2022 | $132.94M | -56.8% |
| 2021 | $307.58M | -56.9% |
| 2020 | $713.53M | +64.6% |
| 2019 | $433.58M | +282.2% |
| 2018 | $113.43M | +12.9% |
| 2017 | $100.49M | -37.6% |
| 2016 | $161.12M | - |